AALL0434 Intensified Methotrexate Nelarabine (Compound 506U78; IND# 52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia
R
Robert Fallon, MD
Primary Investigator
Not Recruiting
1 years - 30 years
All
Phase
N/A
1 Location
Brief description of study
The overall goal of this study is to see if we can get rid of the cancer for as long as possible with acceptable side effects of therapy.
Detailed description of study
The overall goal of this study is to see if we can get rid of the cancer for as long as possible with acceptable side effects of therapy.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Acute Lymphoblastic Leukemia
-
Age: 1 years - 30 years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 1010002648
